[Systemic infection caused by <i>Magnusiomyces</i> spp. in oncohaematological patients]. [PDF]
Vargas-Herrera AI +3 more
europepmc +1 more source
[Relevance of genetic polymorphisms in voriconazole neurotoxicity: case report in a pediatric patient]. [PDF]
Martín-Roldán A +3 more
europepmc +1 more source
Steroid-Refractory Cutaneous Graft-versus-Host Disease: a Case Report [PDF]
Appeceix S +3 more
europepmc +1 more source
[What is new … in the treatment of invasive mycosis: COVID-19-associated pulmonary aspergillosis]. [PDF]
Scharf C, Zoller M, Liebchen U.
europepmc +1 more source
Four-month-old infant with chronic granulomatous disease and invasive aspergillosis with bone involvement [PDF]
Gómez-Tello H +6 more
europepmc +1 more source
Description of the colonizing mycobiota of endotracheal tubes from patients admitted to two intensive care units in Bogotá, Colombia [PDF]
Huertas MG +7 more
europepmc +1 more source
Uso de voriconazol en el período neonatal. Reporte de dos casos
Serious mycotic infections are now more frequent in the intensive care units and they increase morbidity and mortality rates. New antifungal agents have been developed in recent years, including voriconazole.
Ruiz Montes, Miguel Antonio +3 more
core
[Visual diagnosis for experts]. [PDF]
Arheilger L +6 more
europepmc +1 more source
Rapid antifungal susceptibility testing from positive blood cultures using direct gradient diffusion: a prospective study. [PDF]
Gómez-Barral L +4 more
europepmc +1 more source
[Drug-drug interactions in critically ill patients]. [PDF]
Bellmann R, Weiler S.
europepmc +1 more source

